Servier

Showing 11 posts of 26 posts found.

France cleans up regulation – and restricts pharma role

July 14, 2011
Research and Development, Sales and Marketing France, Mediator, Servier, pharmacovigilance, research and development news

France has unveiled sweeping changes to how it regulates prescription medicines following the scandal surrounding Servier’s Médiator. Health minister Xavier …

UK suing Servier over alleged generic blocking

June 7, 2011
Sales and Marketing Peridopril, Servier, generics

The UK government is taking Servier to court for allegedly blocking generic versions of its blood pressure drug Perindopril from …

French pharma firm denies drug risk cover up

May 10, 2011
Sales and Marketing Mediator, Servier, drug safety

France’s second biggest pharma firm Servier has denied allegations it concealed risks associated with its diabetes drug Mediator (benfluorex). Research …

Pressure mounts on Servier over Mediator controversy

February 3, 2011
Sales and Marketing France, G5, Mediator, Servier, benfluorex

Dr Jacques Servier has stepped down from his role as head of a French pharma industry association as controversy grows …

Decision on osteoporosis drug Protelos unchanged, says NICE

January 27, 2011
Sales and Marketing NICE, Protelos, Servier, osteoporotic fractures, strontium ranelate

NICE has published updated final guidance on preventing osteoporotic fractures following a reconsideration of the use of Servier’s Protelos. The …

Servier’s Mediator provokes French drug safety controversy

January 12, 2011
Sales and Marketing AFSSAPS, France, Mediator, Servier, benfluorex, drug safety

Serious questions are being asked about drug safety monitoring in France in connection with Servier’s Mediator (benfluorex) which was withdrawn …

Nycomed COPD iPhone app

Digital Pharma: Pharma iPhone app update

October 15, 2010
Medical Communications Astellas, Boehringer, Digital Pharma blog, GlaxoSmithKline, Lundbeck, Menarini, Nycomed, Pfizer, Servier, Teva, app, iphone

The ranks of pharma iPhone apps are increasing all the time and recent months have seen new additions from Teva, …

Servier fails to overturn NICE osteoporotic guidance

February 2, 2010
Sales and Marketing NICE, Servier, osteoporosis

Servier’s challenge to NICE guidance on preventing osteoporotic fractures has proved unsuccessful, with the watchdog’s original decision still standing. This …

Manufacturing news in brief

December 1, 2009
Manufacturing and Production Aurobindo, Servier

Our periodic round-up of developments in the pharmaceutical manufacturing sector reveals a crop of facility news, with capital investments at …

Servier signs drug discovery deal with Vernalis

May 7, 2009
Research and Development, Sales and Marketing Servier, Vernalis

Servier, France's largest privately-owned pharma company, has signed a new three-year drug discovery deal with Vernalis focused on oncology. UK …

Servier claims victory over NICE in osteoporosis

February 19, 2009
Research and Development, Sales and Marketing NICE, Servier

Servier has claimed victory in the first round of its legal battle against NICE's guidelines on osteoporosis.A judicial review requested …

The Gateway to Local Adoption Series

Latest content